We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
  • SKIP TO CONTENT
  • SKIP NAVIGATION
  • Drug Products
    • Books
    • FDAnews Books Library
    • Events
    • Form 483s Database
    • Subscription Newsletters
    • Free Newsletters
    • Webinar Training Pass
    • eCFR and Guidances
  • Device Products
    • Books
    • FDAnews Books Library
    • Events
    • Form 483s Database
    • Subscription Newsletters
    • Free Newsletters
    • Webinar Training Pass
    • eCFR and Guidances
  • Clinical Products
  • Advertising
  • White Papers
  • Contact Us
  • About Us
  • COVID-19
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Stryker Sued Over Recalled Spinal Plate

Stryker Sued Over Recalled Spinal Plate

May 20, 2014

A lawsuit filed against Stryker claims that the OASYS Midline Occiput Plate, a spinal fusion device, causes metallosis in patients who use it.

According to the complaint, a pin connecting the tulip head to the plate body can break, putting patients at risk of blood loss, nerve damage and metallosis. The plaintiffs also accuse Stryker of stating that the device was made entirely from titanium, then later admitting it contained a combination of cobalt, chromium, molybdenum, titanium and nickel.

The OASYS plate was the focus a May 2013 urgent medical device recall and an August Class I recall — the most serious recall category maintained by the FDA.

The plaintiffs include patients who have used the device since its 2010 FDA approval and patients treated during premarket studies. According to the suit, nine of the 14 plaintiffs participated in the original clinical trial.

Stryker began distributing the devices on April 23, 2010, and less than 3 years later an Urgent Medical Device Recall was announced.

The OASYS Midline Occiput Plate was used to provide stabilization at the junction between the occipital bone and the vertebrae in the cervical spine. — Kellen Owings

Subscribe to Devices & Diagnostics Letter for complete coverage of the medical devices industry. Click here for more information.

Medical Devices Quality Regulatory Affairs QSR Postmarket Safety

Upcoming Events

  • 24Feb

    Virtual Site Training in Clinical Trials: The New Standard

  • 10Mar

    FDA Drug GMP Facility Inspections During the Pandemic

  • 16Mar

    Pharmaceutical Naming Regulation: Understanding the Latest Developments

  • 18Mar

    Pharmaceutical Postmarket Surveillance: Latest Developments in the Era of COVID-19

  • 23Mar

    Data Integrity for GCP Professionals: Core Requirements, Expectations and Challenges

  • 30Mar

    Data Integrity for GMP/Postmarket Professionals: Core Requirements, Expectations and Challenges

Featured Products

  • Biological Risk Evaluation and Management for Medical Devices

  • GMP Inspection Preparation Checklist: A Tool for Internal Auditing

Featured Stories

  • WHO

    J&J Seeks WHO Emergency Use Listing for COVID-19 Vaccine

  • Partner Up, blocks

    Becton Dickinson, Scanwell Health Partnering on COVID-19 Rapid Home Test

  • AstraZeneca

    AstraZeneca Withdraws Imfinzi’s Bladder Cancer Indication

  • CE mark

    Cue Health’s COVID-19 Test Receives CE Mark

The Revised ICH E8: A Guide to New Clinical Trial Requirements

Learn More
  • Drug Products
    • Quality
    • Regulatory Affairs
    • GMPs
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Device Products
    • Quality
    • Regulatory Affairs
    • QSR
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Clinical Products
    • Trial Design
    • Data Integrity
    • GCP
    • Inspections and Audits
    • Transparency
  • Privacy Policy
  • Do Not Sell My Personal Information
Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 703.538.7600 – Fax 703.538.7676 – Toll free 888.838.5578

Copyright © 2021. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing